5,786 trials (keyword fallback)
Wound Healing
Primary: Time to Healing (Days) — 13.1; NA; 13.1; NA days
Arm Lymphedema · Truncal Lymphedema · Breast Cancer
Primary: Arm Volume at End of Study — 2376.52; 2539.93 ml
Acute Wounds From Trauma · Dehiscence or Surgical Complications
Primary: Percent Change Per Day in Wound Surface Area — -4.5; -4.9 % change per day — p=0.60
Pre-eclampsia
Primary: Detection of Fluid in the Lungs — 2; 3 Participants — p=.162
Signs and Symptoms
Primary: Sensitivity — 53 percentage of positive scans
Cardiac Arrest · Sudden Cardiac Death
Primary: Mean Systolic and Diastolic Blood Pressures — 80.38; 121.21; 61.37; 15.52 mmHg
Donor Site Complication
Primary: Number of Participants With Treatment-related AEs and SAEs (Including Infections and Bleeding) — 0; 0; 0; 0 Participants
SURGICAL SITE INFECTION
Primary: Surgical Site Infection — 6; 3 participants — p=<0.05
Open Chest Wounds
Primary: Duration of Negative Pressure Wound Therapy (NWPT) — 8 Days
Hemothorax · Hemopneumothorax; Traumatic · Empyema
Primary: Number of Participants With Retained Hemothorax Following Initial Chest Tube Placement Requiring Intervention — 51; 48 Number of Participants — p=0.036
Chest Pain
Primary: Frequency of Chest Pain Episodes — 1; 3 participants
Lung Cancer
Primary: Safety Measurement — 0; 0; 0; 0 Adverse events
Pain, Procedural · Pain, Postoperative · Coronary Artery Bypass Surgery
Primary: Mediastinal Chest Tube Pain — 1.38; 1.76; 1.43; 0.21 score on a scale
Diabetic Foot Ulcer · Deep Diabetic Foot Ulcer
Primary: Wound Area at 16 Weeks — 6.1; 6.8 cm^2
High Risk Abdominal Wounds
Primary: Number of Participants With Surgical Site Infections Within 1 Month (4 Weeks ) From Index Operation — 1 Participants